NCT00862251
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
See it on ClinicalTrials.gov ↗808 people
47.8%
52.2%
386 womenmiddle line = equal numbers422 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2011-03
- Health conditions
- Cardiovascular Disorder, Diabetes Mellitus
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 64.0 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Patient is pregnant or breast-feeding”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Patient is pregnant or breast-feeding”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Patient is willing to remain abstinent or use birth control for the duration of the study”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Patient has kidney disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Patient has congestive heart failure”
- No diabetes
Women with diabetes were turned away.
“Patient has diabetes mellitus that is not well controlled”
Study titles and rules are shown in their original English.